Hoʻolālā nā mea ʻike kaiapuni i ka maikaʻi o ka ea

Ua hoʻokaʻawale ʻia ka haumia o ka ea o waho a me nā mea particulate (PM) he mau carcinogens kanaka Group 1 no ka maʻi kanesa māmā. He manaʻo ko nā pilina haumia me nā maʻi kanesa hematologic, akā he ʻokoʻa kēia mau maʻi kanesa ma ke ʻano he kumu a nele nā ​​​​hoʻokolohua sub-type.

Nā ʻAno Hana
Ua hoʻohana ʻia ka American Cancer Society Cancer Prevention Study-II Nutrition Cohort e nānā i nā pilina o nā mea haumia o waho me nā maʻi ʻaʻai hematologic makua. Ua hāʻawi ʻia nā wānana makahiki o ka pae hui poloka helu kanaka o nā mea particulate (PM2.5, PM10, PM10-2.5), nitrogen dioxide (NO2), ozone (O3), sulfur dioxide (SO2), a me carbon monoxide (CO) me nā helu wahi noho. Ua kuhi ʻia nā lakio pōpilikia (HR) a me 95% mau manawa hilinaʻi (CI) ma waena o nā mea haumia e loli ana i ka manawa a me nā ʻano hematologic.

Nā Hualoaʻa
Ma waena o 108,002 mau mea komo, ua ʻike ʻia he 2659 mau maʻi ʻaʻai haematologic mai 1992–2017. ʻO nā kiʻekiʻe o ka PM10-2.5 i pili pū me ka lymphoma cell mantle (HR no 4.1 μg/m3 = 1.43, 95% CI 1.08–1.90). Ua pili ʻo NO2 me ka Hodgkin lymphoma (HR no 7.2 ppb = 1.39; 95% CI 1.01–1.92) a me ka marginal zone lymphoma (HR no 7.2 ppb = 1.30; 95% CI 1.01–1.67). Ua pili ʻo CO me ka marginal zone (HR no 0.21 ppm = 1.30; 95% CI 1.04–1.62) a me nā T-cell (HR no 0.21 ppm = 1.27; 95% CI 1.00–1.61) lymphomas.

Nā hopena
ʻAʻole paha i hoʻohaʻahaʻa ʻia ke kuleana o nā mea haumia ea ma nā maʻi ʻaʻai hematologic ma mua ma muli o ke ʻano like ʻole o nā ʻano like ʻole.

Pono mākou i ka ea maʻemaʻe e hanu ai, a ʻo ka hapa nui o nā noi e pono ai nā ʻano ea kūpono e hana pono ai, no laila he mea nui e makaʻala i ko mākou puni. Ma kēia ʻano, hāʻawi mākou i nā ʻano sensor kaiapuni e ʻike i nā mea e like me ka ozone, carbon dioxide a me nā hui organik volatile (VOC).